Mar 12 2015
CannTrust, Canada's only pharmacist-controlled licensed producer and distributor of medical cannabis today announced a collaboration with Canabo Medical Corporation (Canabo) to partner on a research project on marijuana for medical purposes.
Canabo is a leader in patient care for cannabinoids and medical marijuana and will oversee the research through its network of healthcare practitioners at its medical clinics over the next 24 months.
"By capturing and examining real-world data, the outcome goal of the research aims to provide insights into the effects of various strains and its impact to treat a range of chronic conditions," says JC St-Amour, Chief Executive Officer of Canabo. "Data collected will be useful to clinicians, policy makers, patient groups, and the licensed producers involved in the growing and distribution of medical cannabis as a therapeutic modality".
Evidence-based medicine in combination with expert medical advice provides patients with a targeted approach to using medical cannabis in the management of various conditions that have negative health impacts on the patient and their quality of life.
"At CannTrust, patients are our first priority," says Norman Paul, Chairman of CannTrust. "Through the Canabo collaborative research project, we're contributing to the growing body of evidence-based research for the use and efficacy of medical cannabis and, importantly, will be helping our patients to better manage their medical conditions."
SOURCE CannTrust Inc.
Study questions causal link between cannabis and brain changes